Terstappen L W, Huang S, Picker L J
Becton Dickinson Immunocytometry Systems, San Jose, CA 95131.
Blood. 1992 Feb 1;79(3):666-77.
Using multidimensional flow cytometry we have defined and quantified the human T-cell differentiation pathway, focusing on those events occurring among the most immature thymocytes and putative bone marrow (BM) T-precursors. Early thymocytes were found to express the CD34 antigen and consisted of a mean 1.2% of cells within human pediatric (n = 9) and 2.0% in fetal thymi (n = 4). All CD34+ thymocytes were atypical blast by morphology, expressed intracytoplasmatic, but not cell surface, CD3, and were cell surface CD2+, CD5+, CD7+, CD38+, CD45+, CD45RA+, CD49d+, and LECAM-1(Leu8)high. CD34high thymocytes lacked surface expression of CD4 and CD8, but as CD34 expression diminished there was a coordinate increase in CD4 levels, followed by the appearance of CD8. The expression of CD1 and CD10 also increased concomitant with the loss of CD34, whereas expression of LECAM-1 diminished with CD34 downregulation. The differential expression of these antigens on early thymocytes (as well as the number of thymocytes displaying these patterns) was highly reproducible among the nine pediatric and four fetal specimens examined, suggesting a precise, stereotyped regulation of early differentiation events. Cell populations with antigen expression patterns suggestive of pluripotent stem cell (CD34high, CD38-), or non-T-lineage committed stem cells (CD34+, CD33+ or CD34+, CD19+) were not identified in either fetal or pediatric thymi (sensitivity = 1/10(4)). The presence of cells with the antigenic profile of the earliest CD34+ thymocytes was explored in human BM. Putative BM T-cell precursors with the appropriate phenotype (CD34+, CD7+, CD5+, CD2+, LECAM-1high) were readily identified in fetal specimens (constituting +/- 2% of the CD34+ population), but could not be reliably detected in adults. In contrast with thymi, only 13% of these cells expressed cytoplasmatic CD3, suggesting the presence of the immediate precursor of the putative prothymocyte population. This was further supported by the detection of CD34bright, CD7+, CD2-, CD5-, LECAM-1moderate cells in fetal specimens. Our results document the flow of cell surface differentiation during T-lymphopoiesis and suggest that T-lineage features are first acquired in the BM. The ability to reproducibly identify and isolate T-cell precursor populations of precisely defined maturational stage in marrow and thymus by multiparameter flow cytometry will facilitate characterization of the molecular events controlling T-lineage differentiation.
我们运用多维流式细胞术对人类T细胞分化途径进行了定义和定量分析,重点关注最不成熟的胸腺细胞和假定的骨髓(BM)T前体细胞中发生的事件。研究发现,早期胸腺细胞表达CD34抗原,在人类儿童胸腺(n = 9)中占细胞总数的平均比例为1.2%,在胎儿胸腺(n = 4)中为2.0%。所有CD34+胸腺细胞在形态上均为非典型母细胞,表达胞质内而非细胞表面的CD3,细胞表面表达CD2+、CD5+、CD7+、CD38+、CD45+、CD45RA+、CD49d+以及高表达LECAM-1(Leu8)。CD34高表达的胸腺细胞缺乏CD4和CD8的表面表达,但随着CD34表达的减少,CD4水平相应增加,随后出现CD8。CD1和CD10的表达也随着CD34的丢失而增加,而LECAM-1的表达则随着CD34下调而减少。在检查的9例儿童和4例胎儿标本中,这些抗原在早期胸腺细胞上的差异表达(以及呈现这些模式的胸腺细胞数量)具有高度可重复性,这表明早期分化事件受到精确、刻板的调控。在胎儿或儿童胸腺中均未鉴定出具有多能干细胞(CD34高表达、CD38-)或非T系定向干细胞(CD34+、CD33+或CD34+、CD19+)抗原表达模式的细胞群体(灵敏度 = 1/10⁴)。我们在人类骨髓中探索了具有最早CD34+胸腺细胞抗原特征的细胞的存在情况。在胎儿标本中很容易鉴定出具有适当表型(CD34+、CD7+、CD5+、CD2+、高表达LECAM-1)的假定骨髓T细胞前体细胞(占CD34+群体的±2%),但在成人中无法可靠检测到。与胸腺不同,这些细胞中只有13%表达胞质CD3,这表明存在假定的原胸腺细胞群体的直接前体。胎儿标本中检测到CD34明亮、CD7+、CD2-、CD5-、中等表达LECAM-1的细胞进一步支持了这一点。我们的结果记录了T淋巴细胞生成过程中细胞表面分化的流程,并表明T系特征首先在骨髓中获得。通过多参数流式细胞术可重复地鉴定和分离骨髓和胸腺中精确确定成熟阶段的T细胞前体群体,这将有助于表征控制T系分化的分子事件。